Comments

Kronos Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Kronos Bio (KRON) operate in?

Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

KRONNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Tue Mar 18th, after the market close

Kronos Bio (KRON) Forecast

News Earnings Kronos Bio (KRON) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Kronos Bio Stock Price, Quotes and Forecasts | NASDAQ:KRON | Benzinga

Explore Kronos Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KRON.

Open	$0.87
Close	-
Volume / Avg.	15.74K / 237.17K
Day Range	$0.85 - $0.88
52 Wk Range	0.69 - 1.60
Market Cap	$51.98M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	1.86%
Days to Cover	5.58

Recent News

Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul

Kronos Bio announces major leadership changes and an 83% workforce reduction as part of a strategic overhaul, with stock gaining in premarket.

Nabaparna Bhattacharya

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining

Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.

Anthony Noto

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

Anthony Noto

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.87
Close	-
Volume / Avg.	15.74K / 237.17K
Day Range	$0.85 - $0.88
52 Wk Range	0.69 - 1.60
Market Cap	$51.98M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	1.86%
Days to Cover	5.58

About Kronos Bio Inc

Sector

Health Care

Industry

Biotechnology

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kronos Bio (KRON) stock?

You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.

View our list of the best stock brokerages

Who are Kronos Bio (KRON) competitors?

Other companies in Kronos Bio’s space includes: Serina Therapeutics (AMEX:SER), Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX) and Gain Therapeutics (NASDAQ:GANX).

What is the forecast, or price target, for Kronos Bio (KRON) stock?

Kronos Bio has a consensus price target of $7.31.

What is the current price for Kronos Bio (KRON)?

The stock price for Kronos Bio (NASDAQ: KRON) is $0.8525 last updated March 25, 2025 at 10:00 AM EDT.

Does Kronos Bio (KRON) pay a dividend?

There are no upcoming dividends for Kronos Bio.

When is Kronos Bio (NASDAQ:KRON) reporting earnings?

Kronos Bio’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Kronos Bio (KRON) going to split?

There is no upcoming split for Kronos Bio.

What sector and industry does Kronos Bio (KRON) operate in?

Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.